CDW faculty Bios and Pictures
 Dr Kristy A. Brown, Ph.D. | Dr. Brown is an NHMRC (Australia) Career Development Fellow and Co-Head of the Metabolism & Cancer laboratory at Prince Henry’s Institute, and an adjunct lecturer in the Department of Physiology at Monash University. Dr Brown has over 10 years experience in sex hormone biology, specialising in the study of the regulation of enzymes involved in the biosynthesis of sex hormones. Her research interests are aimed at elucidating the mechanisms whereby dysregulated metabolism leads to the increased risk of breast cancer. Her recent work identified the LKB1/AMPK pathway, central regulator of energy homeostasis, as a modulator of oestrogen production within the breast, thereby providing a molecular link between obesity and breast cancer. Dr. Brown’s current research interests include understanding metabolic signalling pathways which regulate oestrogen production in the breast adipose in the context of obesity and cancer, and to investigate potential therapeutics that target these pathways in the clinical setting
 Marie Gelato, MD, PhD I Dr. Gelato is a Distinguished Service Professor of Medicine, Division of Endocrinology at Stony Brook University. She is the Director of the NIH K 30 Program for clinical research education and has been a GCRC Program Director. She has over 20 years-experience doing investigator initiated patient oriented research. Her major area of investigation is the metabolic complications of HIV disease. She was a member of the FDA Advisory Panel for Endocrine and Metabolic Drugs and still serves as an ad hoc member. She has served on several NIH review panels including reviews for K 23 awards and the Loan Repayment Program. She has been a mentor to over 20 fellows during her tenure at Stony Brook University. Dr. Gelato has been President of the Association for Patient Oriented Research (APOR) in the last year and has served as a Board member in the organization for several years Deborah J. Good, PhD | Dr. Good obtained her Ph.D. in Molecular and Cellular Biology from Northwestern University in 1992. While at Northwestern, Dr. Good studied tumor suppressor gene control of angiogenesis and she was awarded a patent for her work to identify a naturally-occurring inhibitor of angiogenesis, thrombospondin. Dr. Good went on to a postdoctoral fellowship at the National Institutes of Health, in the National Cancer Institute where she began to characterize the role of two basic helix-loop-helix transcription factors in the developing nervous system. In 1997, Dr. Good accepted a position for a tenure-track Assistant Professor in the Department of Veterinary and Animal Sciences at the University of Massachusetts-Amherst, where she was awarded tenure in 2003. In the past 13 years she has secured over 1.77 million dollars in awards have supported her research and published over 40 journal articles and book chapters on the genetics of body weight regulation. Her passion for promoting research for undergraduates and minority students is evidenced as she is PI of a grant that established a new summer undergraduate research program for HNFE ($139,097 +100% matching), and has mentored one VT Prep Scholar, one McNair summer scholar, and two minority high school students in the Ag Scholars program. She has trained 3 postdoctoral fellows, 8 Ph.D. students and 3 M.S. students over her career
Chyren Hunter, PhD | Dr. Hunteris the Deputy Director and Research Training Officer, Division of Extramural Activities, National Institute on Aging, National Institutes of Health.She oversees a broad range of activities governing the review and funding of research applications and the management of grants supporting research on aging and geriatrics. As Training Officer, she has overall responsibility for research training programs supporting predoctoral and postdoctoral fellows and clinician-scientists pursuing careers in aging research.Dr. Hunter began her career at the NIH as an Intramural Research Training Award fellow. Her research focused on glutamate neurotransmission in the mammalian central auditory system. Prior to her current position she was a Program Director and Training Officer with the National Eye Institute. She received her B.A. in Bio-Psychology from Wesleyan University, Middletown, CT. and her doctorate in Biomedical Sciences from the Mount Sinai School of Medicine through the Biomedical Sciences Doctoral Program of the City University of New York  Barry Komm, PhD | Dr. Komm is currently the Senior Director of Scientific Affairs and Global Medical Affairs at Wyeth-Ayerst in Collegeville, Pennsylvania. Dr. Komm received his Bachelor’s and Master’s degrees from the University of Missouri from 1974-1975. He went on to complete his PhD degree at the University of South Florida in 1982. His post-doctoral research landed him at the Universty of Pennsylvania, Department of OB/GYN, Division of Reproductive Biology. He became an Assistant and Associate Professor at the Universities of Arizona and Pennsylvania, respectively, before climbing the ranks in 1993 at Wyeth-Ayerst. Dr. Komm’s research focuses on osteoporosis and cell biology, particularly at the Women’s Health Research Institute. Dr. Komm’s involvement in Global Medical Affairs allows him to connect science and product with brand messaging, profiled definition, market research, naming, and brand equity. Dr. Komm has published approximately one hundred articles, papers, and book chapters. Fredric B. Kraemer, MD | Dr. Kraemer received his Bachelor's degree in Chemistry from Emory University in 1970 and his M.D. from New York University in 1974. He was a house officer in Internal Medicine at Kings County/Downstate Medical Center (1974-1978) and a postdoctoral fellow in Endocrinology at Stanford University (1978-1982). He joined the faculty in the Department of Medicine at Stanford in 1983. Dr. Kraemer currently holds the Stanford University Professorship in Endocrinology and is the Chief of the Division of Endocrinology, Gerontology and Metabolism, as well as a staff physician at the VA Palo Alto Health Care System. His research interests are focused on studies of cellular lipid metabolism.
Dr. Lakoski also served as the inaugural Associate Dean for Postdoctoral Education at the University of Pittsburgh, School of Medicine (2005-2010) and was honored by the University of Pittsburgh Postdoctoral Association for her numerous activities in support of postdoctoral fellows at Pitt as the recipient of the 2007 Postdoctoral Advocate Award. Under Dr. Lakoski’s leadership, the Schools of the Health Sciences developed an innovative course for senior postdoctoral fellows and junior faculty to develop their abilities to lead and manage innovative research programs (Scientific Management and Leadership Course). Dr. Lakoski currently is Director of the Ri.MED Foundation Postdoctoral Fellows Program – an innovative international postdoctoral training program at the University of Pittsburgh. She is also the Founding and Executive Director of the Office of Science Education Outreach, Health Sciences (OSEO), at the University of Pittsburgh. Established in 2010, OSEO is dedicated to empowering K-16 students, including high school students and undergraduate students; teachers, parents and other community supporters; and volunteers from across the academic health center to work as partners in exploring the opportunities in sciences, including careers in the discovery, dissemination, and translation of biomedical knowledge that will improve human health (see www.howscienceworks.pitt.edu).
 Zhenqi Liu, MD | Dr. Liu is a Board-certified Endocrinologist, Professor of Medicine, and Chief of the Division of Endocrinology and Metabolism at the University of Virginia. He received medical degree in China, completed Internal Medicine residency at the Washington Hospital Center and clinical fellowship in Endocrinology and Metabolism at the University of Virginia. In addition, he received research training as a postdoctoral fellow at both Yale University and the University of Virginia Dr. Liu joined the faculty at the University of Virginia in 2000. He practices general endocrinology with special interests in diabetes, thyroid nodule and thyroid cancer. His research focuses on insulin action and diabetes complications, and is funded by both NIH and the American Diabetes Association. He sits on many grant review panels and journal editorial boards and has chaired many national and international symposia.  David Maggs, MD | Dr. Maggs is Vice President for Medical Development and the Medical Lead for the Exenatide franchise at Amylin Pharmaceuticals. Before joining Amylin in 2000, Dr Maggs had prior industry experience through Medical leadership positions at Warner Lambert and Pfizer. A trained Endocrinologist, Dr Maggs graduated from Guys Hospital Medical School in London, England, and later completed postgraduate studies at the University of Nottingham, and fellowship and faculty appointments at Yale School of Medicine in New Haven, Conn Ronald Margolis, BSC, PhD | Dr. Margolis is the Senior Advisor for Molecular Endocrinology in the Division of Diabetes, Endocrinology and Metabolic Diseases at NIDDK (NIH). Dr. Margolis received his B.S. degree from the University at Albany and Ph.D. from the Health Sciences Center at Syracuse. He obtained post-doctoral training at the University of Virginia and came to the NIH in 1989 after an academic career at the Howard University Cancer Center. At the NIH Dr. Margolis has developed and maintained a portfolio of grants focused on the role of the nuclear hormone receptor superfamily in health and disease, including work as the Project Scientist for the Nuclear Receptor Signaling Atlas (NURSA). Dr. Margolis is also Science Officer for the Molecular Libraries Production Centers Network, a trans-NIH Common Fund project. Dr. Margolis is also Project Scientists for the NIDDK Consortium Interconnectivity Network (dkCOIN), a trans-NIDDK informatics effort designed to develop a common approach to community-wide access to the results of “Big-Data” projects. Dr. Margolis is the recipient of the Sidney Ingbar award from the Endocrine Society and is a three-time awardee of the NIH Director's award.  Frank A. Quinn, PhD, FACB | Dr. Quinn is Director of Global Scientific Affairs at Abbott Diagnostics, where his responsibilities include the coordination of external research studies, and the development of scientific publications and medical education programs. Currently, his work is focused on the areas of endocrinology, maternal health, and acute kidney injury. Dr. Quinn has been with Abbott Diagnostics for over 20 years, and during this time has worked in a broad range of areas in the field of clinical biochemistry. He has also collaborated with colleagues in the pharmaceutical industry on projects in a number of therapeutic areas, including thyroid disease, rheumatoid arthritis, therapeutic drug monitoring, reproductive health, and kidney disease. He has extensive international experience, and has developed and presented symposia, industry sponsored workshops, and continuing education programs in over 40 countries. Prior to his position in Scientific Affairs, he was involved in thyroid hormone immunoassay research and development for the Abbott IMx, AxSYM, and ARCHITECT automated immunoassay systems. He received his Ph.D. in Chemistry from the
Simon J. Rhodes, Ph.D. | Dr. Rhodes is the Dean of the School of Science at Indiana University-Purdue University Indianapolis. He also is professor of Biology and a professor in the Departments of Cellular & Integrative Physiology and Biochemistry & Molecular Biology at the Indiana University School of Medicine. He received a B.Sc. Hons. Bio-chemistry from the University of Sheffield, U.K., the Ph.D. in biochemistry from Purdue University, Indiana, U.S.A., and did postdoctoral work in molecular medicine at the University of California San Diego. Dr. Rhodes is a member of the Endocrine Society Trainee & Career Development Core Committee. Dr. Rhodes’ research focuses on characterization of the molecular pathways that control the development of the pituitary gland. His laboratory seeks to understand the nature of pediatric hormone deficiency diseases.  Mark S. Roberson, PhD | Dr. Roberson is currently Professor of Physiology and Chair of the Department of Biomedical Sciences at the College of Veterinary Medicine at Cornell University. He received his PhD training at the University of Nebraska-Lincoln in reproductive physiology followed by postdoctoral training in molecular endocrinology at the medical schools at the University of Iowa and Oregon Health Sciences University. Dr. Roberson joined the faculty at Cornell University in 1995. Major research interests include signaling mechanisms involved in GnRH action in the pituitary gland and transcriptional determinants regulating placental trophoblast function in the mouse and human. In addition, Dr. Roberson serves as the Director of the Reproductive Sciences and Genomics training program at Cornell. Ellen Seely, MD | Dr. Seely is Director of Clinical Research for the Endocrinology, Diabetes and Hypertension Division, Vice Chair, Faculty Development, Department of Medicine at Brigham and Women’s Hospital, and Professor of Medicine at  Dolores Shoback, MD | Dr. Shoback is Professor of Medicine at the University of California, San Francisco (USCF) and is the Associate Program Director of the UCSF Fellowship Training Program in Diabetes, Endocrinology and Metabolism. She is a Staff Endocrinologist at the San Francisco Department of Veterans Affairs Medical Center. She is engaged in basic research on mechanisms underlying the regulation of parathyroid hormone secretion and on the role of calcium-sensing receptors in the control of bone cell and chondrocyte differentiation and parathyroid hormone secretion. She was involved in 4 multicenter clinical trials testing the efficacy and safety of the calcimimetic cinacalcet in the treatment of patients with primary hyperparathyroidism and parathyroid cancer and in clinical trials on the use of parathyroid hormone (PTH 1-84) in the treatment of refractory hypoparathyroidism. Her clinical work involves all areas of Endocrinology with special interest in metabolic bone and parathyroid disorders and the diagnosis and management of osteoporosis. Dr. Shoback has served the Endocrine Society as Program Chair of the Postgraduate Assembly & Director of Clinical Endocrinology Updates. She has also been actively involved as a member of several committees including: The Scientific and Educational programs, Broadcast Steering, Special Programs, Meeting and Educational Programs, Annual Meeting programs, Publications Committees, special programs committees and she served as the Clinical Science and Practice chair for the Annual Meetings Steering Committee of The Endocrine Society. Dr. Shoback currently serves as a member for The Endocrine Society’s Council. Her research has been funded by the Research Service of the Department of Veteran Affairs and the NIH. She has received Research Associate and Clinical Investigator Career Development Awards from the Department of Veterans Affairs.
 Jason Wexler, MD | Dr. Wexler completed his undergraduate studies at Cornell University and received his medical degree from State University of New York Health Science Center at Brooklyn, where he was elected to Alpha Omega Alpha. He completed his internship and residency at University of Michigan in Ann Arbor and graduated from the Endocrinology, Diabetes and Metabolism fellowship at New York Presbyterian Hospital - Weill Cornell University Medical Center. He was an Assistant Professor of Medicine at University of California, Davis Medical Center and is currently a member of the Section of Endocrinology at Washington Hospital Center and a Clinical Assistant Professor of Medicine at Georgetown University Hospital in Washington, DC. He has been actively involved in committee work for the Endocrine Society and is the Chair of the Clinical Affairs Core Committee Christine Whorton, MHA | Christine’s career in health care began as an admitting clerk at the Ohio State University Hospitals in Columbus, OH as she worked her way to a bachelor’s degree from OSU. Later she was Assistant Director of Nursing Administration at the George Washington University Medical Center in Washington, DC. While in that position Christine earned a master’s degree in health planning in 1980. After earning the master’s degree, Christine worked for several professional societies in Washington, DC including The American Association for Clinical Chemistry, The American Association of University Women, and, as executive director, the National Association of Foreign Trade Zones. In 1990 Christine’s husband retired and they relocated to Tucson, AZ. Christine then formed Christine Whorton and Associates LLC to provide management consulting services to not-for-profit organizations and associations. Her clients include the Endocrine Society where, for the past 21 years, she has managed the Society’s classified advertising and employment and recruitment consulting services Jonathan Williams, MD | Dr. Williams is an endocrinologist and clinical researcher at Brigham and Women’s Hospital. He is an Assistant Professor of Medicine at Harvard Medical School where he directs courses on the principles of patient-oriented research. His research interests focus on deciphering the hormonal and genetic contributions to cardiovascular diseases including hypertension, insulin resistance and obesity. His research activities are funded in part through an NIH K23 Mentored Career Development Award the topic of which he lectures frequently. Joy Wu, MD, PhD | Dr. Wu received her M.D. and Ph.D. degrees from Duke University. She pursued residency training in Internal Medicine at Brigham and Women’s Hospital, and completed a clinical fellowship in Endocrinology, Diabetes, and Metabolism at Massachusetts General Hospital. Dr. Wu is an Instructor in Medicine at Harvard Medical School, where her research focuses on skeletal development with a clinical emphasis on osteoporosis. She served as Co-Chair for the Endocrine Society’s Trainee and Career Development Core Committee from 2006-2010 |
|
CDW at ENDO 2012
Supporter
|
